| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 06:31:27 UTC |
|---|
| Update Date | 2022-11-30 19:26:24 UTC |
|---|
| HMDB ID | HMDB0115950 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
|---|
| Description | CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of osbond acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids). |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C50H83N3O15P2/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-46(55)66-42(39-63-45(54)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2)40-64-69(59,60)68-70(61,62)65-41-43-47(56)48(57)49(67-43)53-38-37-44(51)52-50(53)58/h11,13,17-18,20-21,24,26,30,32,37-38,42-43,47-49,56-57H,3-10,12,14-16,19,22-23,25,27-29,31,33-36,39-41H2,1-2H3,(H,59,60)(H,61,62)(H2,51,52,58)/b13-11-,18-17-,21-20-,26-24-,32-30-/t42-,43-,47+,48?,49-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Palmitoyl-2-osbondoyl-sn-glycero-3-CDP | HMDB | | 1-Palmitoyl-2-osbondoyl-sn-glycero-3-cytidine-5'-diphosphate | HMDB | | CDP-DG(16:0/22:5) | HMDB | | CDP-DG(16:0/22:5N6) | HMDB | | CDP-DG(16:0/22:5W6) | HMDB | | CDP-DG(38:5) | HMDB | | CDP-Diacylglycerol(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) | HMDB | | CDP-Diacylglycerol(16:0/22:5) | HMDB | | CDP-Diacylglycerol(16:0/22:5N6) | HMDB | | CDP-Diacylglycerol(16:0/22:5W6) | HMDB | | CDP-Diacylglycerol(38:5) | HMDB | | {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({[(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinate | HMDB | | 1-palmitoyl-2-osbondoyl-sn-glycero-3-CDP | SMPDB, HMDB | | 1-palmitoyl-2-osbondoyl-sn-glycero-3-cytidine-5'-diphosphate | SMPDB, HMDB | | CDP-DG(16:0/22:5) | SMPDB, HMDB | | CDP-DG(16:0/22:5n6) | SMPDB, HMDB | | CDP-DG(16:0/22:5w6) | SMPDB, HMDB | | CDP-DG(38:5) | SMPDB, HMDB | | CDP-diacylglycerol(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) | SMPDB, HMDB | | CDP-diacylglycerol(16:0/22:5) | SMPDB, HMDB | | CDP-diacylglycerol(16:0/22:5n6) | SMPDB, HMDB | | CDP-diacylglycerol(16:0/22:5w6) | SMPDB, HMDB | | CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) | SMPDB |
|
|---|
| Chemical Formula | C50H83N3O15P2 |
|---|
| Average Molecular Weight | 1028.168 |
|---|
| Monoisotopic Molecular Weight | 1027.529942981 |
|---|
| IUPAC Name | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid |
|---|
| Traditional Name | [(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy([(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(hexadecanoyloxy)propoxy(hydroxy)phosphoryl]oxy)phosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C50H83N3O15P2/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-46(55)66-42(39-63-45(54)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2)40-64-69(59,60)68-70(61,62)65-41-43-47(56)48(57)49(67-43)53-38-37-44(51)52-50(53)58/h11,13,17-18,20-21,24,26,30,32,37-38,42-43,47-49,56-57H,3-10,12,14-16,19,22-23,25,27-29,31,33-36,39-41H2,1-2H3,(H,59,60)(H,61,62)(H2,51,52,58)/b13-11-,18-17-,21-20-,26-24-,32-30-/t42-,43-,47+,48?,49-/m1/s1 |
|---|
| InChI Key | KNGMBZPISHXAJU-LZLHQXFYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cdp-diacylglycerols. These are glycerolipids containing a diacylglycerol, with a cytidine diphosphate attached to the oxygen O1 or O2 of the glycerol part. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | CDP-glycerols |
|---|
| Direct Parent | CDP-diacylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cdp-diacylglycerol
- Pyrimidine ribonucleoside diphosphate
- Diacyl-glycerol-3-pyrophosphate
- Pentose phosphate
- Pentose-5-phosphate
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Organic pyrophosphate
- Pentose monosaccharide
- Aminopyrimidine
- Fatty acid ester
- Pyrimidone
- Monoalkyl phosphate
- Imidolactam
- Pyrimidine
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Dicarboxylic acid or derivatives
- Hydropyrimidine
- Organic phosphoric acid derivative
- Monosaccharide
- Tetrahydrofuran
- Heteroaromatic compound
- Secondary alcohol
- Amino acid or derivatives
- 1,2-diol
- Carboxylic acid ester
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Carboxylic acid derivative
- Alcohol
- Organonitrogen compound
- Organic nitrogen compound
- Organooxygen compound
- Amine
- Carbonyl group
- Primary amine
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.81 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 27.3208 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.9 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5156.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 172.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 330.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 214.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 900.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1575.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1141.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 316.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2827.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1254.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2538.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1101.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 679.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 190.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 249.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.4 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-13 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 10V, Positive-QTOF | splash10-03di-1911001000-a1e0b859f22d204b81f2 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 20V, Positive-QTOF | splash10-03di-2911000100-b01c02f727da6b9661fb | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 40V, Positive-QTOF | splash10-03di-3921000000-c3a06f07821da0ea7048 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 10V, Negative-QTOF | splash10-0bt9-2893001202-f51ee64bd1a22d5e41b9 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 20V, Negative-QTOF | splash10-0bt9-7793210200-8e243423223566ed9330 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 40V, Negative-QTOF | splash10-0a6r-5911000000-47ad52c6fbabb0237219 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 10V, Negative-QTOF | splash10-004i-9001003000-e5770a8037cc555da89a | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 20V, Negative-QTOF | splash10-056u-9043702000-158f12d2fea44ae03850 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 40V, Negative-QTOF | splash10-0a4i-9358300300-733921bf70d8023ec4b6 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 10V, Positive-QTOF | splash10-004i-9100000003-268602ffbafbf2174c96 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 20V, Positive-QTOF | splash10-07vi-5010000009-48152599d76e7243f39f | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 40V, Positive-QTOF | splash10-00du-0197710002-6f1fb5479206be34a9f5 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|